Duhuo Jisheng Decoction mitigates postmenopausal rheumatoid arthritis by suppressing eEF2K-mediated cellular senescence
Pharmacological Research · 2025-12 · 222 · 108013
DOI: 10.1016/j.phrs.2025.108013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2025-12. Verfasst von Danli Chen und 21 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome/ The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Provi…. Hauptthemen laut MEDLINE: Elongation Factor 2 Kinase, Arthritis, Rheumatoid, Cellular Senescence, Arthritis, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) disproportionately impacts middle-aged and elderly women, with postmenopausal RA (PM-RA) showing more severe inflammation and bone destruction than nonmenopausal RA. Despite its clinical significance, the molecular mechanisms underlying this disease subtype remain inadequately characterised, which has hindered the development of targeted therapies. In this study, to explore potential molecular targets, we analysed clinical samples and found that eukaryotic elongation factor-2 kinase (eEF2K) expression in peripheral blood mononuclear cells (PBMCs) was significantly higher in RA patients aged ≥ 60 years (a population highly overlapping with PM-RA) than in those aged ≤ 40 years and 40-60 years (P = 0.0001). Subsequently, in vitro experiments were conducted to clarify the functional role of eEF2K: treatment with the pharmacological eEF2K inhibitor NH125 suppressed the release of proinflammatory cytokines and osteoclastogenesis, which was associated with reduced cell cycle arrest and inhibition of the senescence-associated secretory phenotype (SASP). We evaluated the therapeutic effect of Duhuo Jisheng Decoction (DHJSD) in a preclinical model using an ovariectomy (OVX)-augmented adjuvant-induced arthritis (AIA) model (Sprague-Dawley (SD) females, 4 weeks old) and found that DHJSD effectively alleviated joint inflammation and bone erosion in these rats. We further validated DHJSD's mechanism of action, and DHJSD downregulated eEF2K expression in the bones and PBMCs of model rats, accompanied by attenuation of biomarkers related to cell cycle dysfunction and SASP. Notably, compared with AIA control rats, AIA+OVX rats exhibited aggravated arthritis symptoms and upregulated eEF2K expression (P = 0.031), and DHJSD exerted a model-specific therapeutic effect by modulating eEF2K in these PM-RA-like rats. Statistical analyses were performed with one-way or two-way ANOVA followed by Dunnett's post test. In conclusion, our study demonstrates that DHJSD acts as a novel eEF2K inhibitor and presents a promising therapeutic candidate for PM-RA, while also highlighting eEF2K as a key molecular target mediating the pathological features of PM-RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Traditional Chinese Medicine Syndrome/ The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province 510405, China; Chinese Medicine Guangdong Laboratory/ Hengqin Labo…
- State Key Laboratory of Traditional Chinese Medicine Syndrome/ The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province 510405, China; Department of Anesthesiology, The Second Affiliated…
- Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: tanjing84@outlook.com.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, D., Chen, Y., Yang, X., Li, R., He, F., Xiao, Y., Quan, M., Pang, B., Chen, X., Xian, L., He, X., Shu, Y., Guo, W., Ouyang, J., Liu, P., Ren, H., Lu, J., He, J., Chen, Z., …, & Pan, H. (2025). Duhuo Jisheng Decoction mitigates postmenopausal rheumatoid arthritis by suppressing eEF2K-mediated cellular senescence. Pharmacological Research, 222, 108013. https://doi.org/10.1016/j.phrs.2025.108013
Vancouver
Chen D, Chen Y, Yang X, Li R, He F, Xiao Y, et al. Duhuo Jisheng Decoction mitigates postmenopausal rheumatoid arthritis by suppressing eEF2K-mediated cellular senescence. Pharmacological Research. 2025;222:108013. doi:10.1016/j.phrs.2025.108013
BibTeX
@article{Chen2025,
author = {Chen, Danli and Chen, Yulian and Yang, Xiaonan and Li, Runze and He, Fan and Xiao, Yao and Quan, Minqi and Pang, Biyi and Chen, Xiaoman and Xian, Leyao and He, Xizi and Shu, Yongkang and Guo, Wanyi and Ouyang, Jianjie and Liu, Pingping and Ren, Hong and Lu, Jiayan and He, Jiayan and Chen, Zhengmin and Tan, Jing and Liu, Liang and Pan, Hudan},
title = {Duhuo Jisheng Decoction mitigates postmenopausal rheumatoid arthritis by suppressing eEF2K-mediated cellular senescence},
journal = {Pharmacological Research},
year = {2025},
volume = {222},
pages = {108013},
doi = {10.1016/j.phrs.2025.108013}
}
EUVIMED